Investment analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Merus in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A.

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

After more than a decade of planning, a 4.5-mile portion of U.S. Highway 212’s four-lane expansion has begun.Stretching from Cologne (Highway 36) to Carver (Highway 11/Jonathan Carver ...

Leonteq AG (SIX: LEON) today announced the appointment of Christian Spieler as Leonteq’s CEO effective 1 March 2025.

The Bank of England looks set to cut interest rates on Thursday for only the third time since just after the start of the ...

As rival banks like JPMorgan and Goldman Sachs mandate five days in the office, Citi sees its hybrid schedule as a key ...

The commercial banking operation is Citi's most unique business, as its global footprint is hard to replicate. This international presence will help Citigroup remain a bank of choice for cross-border ...

Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...

The former Florida Coastal School of Law building got the top score in the first phase of Citizens Property Insurance's ...

Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing ...

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research ...

Citigroup has shown significant progress in ... Exiting the expense-intensive phase of its operational restructuring, Citi looks set to drive meaningful revenue growth on improved competitive ...